Search - tctmd.com

Displaying 61 - 80 of 81

Sort: Relevancy | Date

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

May 06, 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

News Conference News EHRA 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

April 16, 2024

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presentation Fellows 2024

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: Jay S. Giri

April 14, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Micra Leadless Pacemaker Performs Well Through 5 Years

News Daily News

Micra Leadless Pacemaker Performs Well Through 5 Years

March 06, 2024

Post PE Syndrome

Presentation THT 2024

Post PE Syndrome

Presenter: Paul Forfia

March 06, 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Case Resolution

Presentation THT 2024

Case Resolution

Presenter: Sareena George

March 06, 2024

Case Presentation

Presentation THT 2024

Case Presentation

Presenter: Sareena George

March 06, 2024

Risk Stratification and Treatment Goals of Acute PE

Presentation THT 2024

Risk Stratification and Treatment Goals of Acute PE

Presenter: Catalin Toma

March 06, 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

Debating the Role of T-TEER in the Sickest Patients

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

February 09, 2024

Assisted Reproductive Technology Linked to Higher Stroke Risk

News Conference News ISC 2024

Assisted Reproductive Technology Linked to Higher Stroke Risk

February 07, 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

January 31, 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

January 30, 2024

Venous Stents: How to Choose Among the Wealth of Options

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

January 26, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.